1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): A multicentre, randomised, controlled, phase 3 trial
    Journal Article

    Fernandez-Bustamante, A.; Parker, R. A.; Frendl, G.; Lee, J. W.; Nagrebetsky, A.; Grecu, L.; Amar, D.; Tanaka, P.; Sprung, J.; Gupta, R. A.; more...
    The Lancet Respiratory Medicine (2025)

    Fulltext@MSK | Save
  • Moving from the background toward the spotlight: A critical review of radiation therapy for locally advanced pancreas cancer
    Review

    Chuong, M. D.; Ashman, J.; Jethwa, K.; Kharofa, J.; Kim, H.; Koay, E.; Ludmir, E.; Miller, E.; Nelson, B.; Reyngold, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • ELAINE 3: Phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer
    Journal Article

    Goetz, M. P.; Wander, S. A.; Bachelot, T.; de Nonneville, A.; Gal-Yam, E. N.; Sammons, S. L.; Shen, S.; Twelves, C.; Boruta, G.; Portman, D. J.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
    Journal Article

    Levis, M. J.; Hamadani, M.; Logan, B. R.; Jones, R. J.; Singh, A. K.; Litzow, M. R.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A. E.; Soiffer, R. J.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Patient-reported outcomes from DESTINY-Breast04: Trastuzumab deruxtecan versus physician’s choice of chemotherapy in patients with HER2-low mBC
    Journal Article

    Ueno, N. T.; Cottone, F.; Dunton, K.; Jacot, W.; Yamashita, T.; Sohn, J.; Tokunaga, E.; Prat, A.; Tsurutani, J.; Park, Y. H.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • History of cancer and atrial cardiopathy: A secondary analysis of the ARCADIA clinical trial
    Journal Article

    Navi, B. B.; Elkind, M. S. V.; Zhang, C.; Tirschwell, D. L.; Kronmal, R. A.; Elm, J.; Broderick, J. P.; Gladstone, D. J.; Beyeler, M.; Kamel, H.; more...
    Journal of the American Heart Association (2025)

    Fulltext@MSK | Save
  • Accurate prediction of absolute prokaryotic abundance from DNA concentration
    Journal Article

    Wirbel, J.; Andermann, T. M.; Brooks, E. F.; Evans, L.; Groth, A.; Dvorak, M.; Chakraborty, M.; Palushaj, B.; Reynolds, G. Z. M.; Porter, I. E.; more...
    Cell Reports Methods (2025)

    Fulltext@MSK | Save
  • Pharmacokinetic profile of novel reduced-dose Danziten(TM) (nilotinib tablets) versus Tasigna® (nilotinib capsules): In vivo bioequivalence and population pharmacokinetic analysis
    Journal Article

    Mauro, M.; Radich, J.; Jain, P.; Sequeira, D.; Bellanti, F.; Douer, D.
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: A randomized phase 3 trial
    Journal Article

    Kopetz, S.; Yoshino, T.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes: MULTIPLE MYELOMA, GAMMOPATHIES
    Journal Article

    Facon, T.; Moreau, P.; Weisel, K.; Goldschmidt, H.; Usmani, S. Z.; Chari, A.; Plesner, T.; Orlowski, R. Z.; Bahlis, N.; Basu, S.; more...
    Leukemia (2025)

    Fulltext@MSK | Save